This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
StemCells Inc
STEM : NASDAQ : Health Care
$1.21 | %
Today's Range: 1.18 - 1.25
Avg. Daily Volume: 743,300
10/17/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
STEM STEMCELLS INC 1.19 81.68 n/m 1.22 17.09
PIP PHARMATHENE INC 1.73 97.64 n/m 14.54 -38.07
ONTX ONCONOVA THERAPEUTICS INC 4.33 93.93 n/m 3.62 512.18
BOTA BIOTA PHARMACEUTICALS INC 2.37 83.19 n/m 68.70 114.01
SNSS SUNESIS PHARMACEUTICALS INC 1.36 82.20 n/m 7.96 27.75
LPDX LIPOSCIENCE INC 5.21 79.96 n/m 46.51 -13.95
SIGA SIGA TECHNOLOGIES INC 1.49 79.72 n/m 4.43 -37.64
TRGT TARGACEPT INC 2.34 79.08 n/m 0.22 -95.59
ISR ISORAY INC 1.40 76.84 n/m 4.22 -6.77
CYCC CYCLACEL PHARMACEUTICALS 3.21 75.24 n/m 1.36 162.04
TROV TROVAGENE INC 4.44 100.16 n/m 0.26 -52.40
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

STEM Ind Avg S&P 500
n/m 79.53 18.06
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs